Common Stock (Tables)
|
3 Months Ended |
May 31, 2026 |
|---|
| Schedule of purchase warrants |
| Schedule of purchase warrants | |
| | | |
| | |
| | |
Number of
Warrants | | |
Weighted Average
Exercise Price | |
| Balance, February 28, 2026 | |
| 8,275,594 | | |
$ | 1.64 | |
| Correction of prior warrant count adjustment | |
| (25,333 | ) | |
| 1.50 | |
| Balance, May 31, 2026 | |
| 8,250,261 | | |
$ | 1.37 | |
|
| Schedule of share purchase warrants outstanding and exercisable |
| | Schedule of share purchase warrants outstanding and exercisable | | |
| | | |
| | | |
|
| | | |
Number of
Warrants | | |
Remaining
Contractual | | |
|
| Exercise Price | | |
Outstanding | | |
Life (Years) | | |
Expiry Date |
| | 0.94 | | |
| 3,950,261 | | |
| 3.57 | | |
December 23, 2029 |
| | 1.65 | | |
| 3,000,000 | | |
| 0.89 | | |
April 20, 2027 |
| | 2.15 | | |
| 1,000,000 | | |
| 0.89 | | |
April 20, 2027 |
| | 1.65 | | |
| 300,000 | | |
| 0.91 | | |
April 27, 2027 |
| | 1.37 | | |
| 8,250,261 | | |
| | | |
|
|
| Schedule of stock option activity |
| Schedule of stock option activity | |
| | | |
| | |
| | |
Number of
Stock Options | | |
Exercise
Price | |
| Balance, February 28, 2026 | |
| 6,039,100 | | |
$ | 4.18 | |
| Cancelled/Forfeited | |
| — | | |
| — | |
| Balance, May 31, 2026 | |
| 6,039,100 | | |
$ | 4.18 | |
|
| Schedule of unvested restricted stock |
| Schedule of unvested restricted stock | |
| | | |
| | |
| | |
Number of
Unvested
Stock Options | | |
Weighted
Average
Grant Date
Fair Value | |
| Balance, February 28, 2026 | |
| 1,059,400 | | |
$ | 4.58 | |
| Vested | |
| — | | |
$ | — | |
| Balance, May 31, 2026 | |
| 1,059,400 | | |
$ | 4.58 | |
|
| Schedule of stock options |
| Schedule of stock options | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
| | |
Options Outstanding | | |
Options Exercisable | | |
| |
Range of Exercise Prices | |
Outstanding at May 31,
2026 | | |
Exercise
Price | | |
Weighted
Average
Remaining Contractual
Term (Years) | | |
Exercisable
at May 31,
2026 | | |
Exercise
Price | | |
Weighted
Average
Remaining Contractual
Term (Years) | |
| | |
| | |
| | |
| | |
| | |
| | |
| |
| $ 3.00 to $ 4.00 | |
| 3,390,600 | | |
$ | 3.84 | | |
| 0.58 | | |
| 3,390,600 | | |
$ | 3.84 | | |
| 0.58 | |
| $ 4.00 to $ 5.00 | |
| 2,648,500 | | |
$ | 4.62 | | |
| 2.16 | | |
| 1,589,100 | | |
$ | 4.62 | | |
| 2.16 | |
| | |
| 6,039,100 | | |
| | | |
| | | |
| 4,979,700 | | |
| | | |
| | |
|
| Individuals 40 [Member] |
|
| Schedule of valuation assumptions |
| Schedule of valuation assumptions | |
| | | |
| | |
| | |
May 31, 2026 | | |
February 28, 2026 | |
| Expected Risk-Free Interest Rate | |
| 1.06 | % | |
| 1.06 | % |
| Expected Volatility | |
| 15.27 | % | |
| 15.27 | % |
| Expected Life in Years | |
| 0.58 | | |
| 0.83 | |
| Expected Dividend Yield | |
| — | | |
| — | |
| Weighted-Average Grant Date Fair Value | |
$ | 6.46 | | |
$ | 6.46 | |
|
| Individuals 22 [Member] |
|
| Schedule of valuation assumptions |
| Schedule of valuation assumptions | |
| | | |
| | |
| | |
May 31, 2026 | | |
February 28, 2026 | |
| Expected Risk-Free Interest Rate | |
| 5.37 | % | |
| 5.37 | % |
| Expected Volatility | |
| 25.48 | % | |
| 25.48 | % |
| Expected Life in Years | |
| 2.16 | | |
| 2.41 | |
| Expected Dividend Yield | |
| — | | |
| — | |
| Weighted-Average Grant Date Fair Value | |
$ | 4.58 | | |
$ | 4.58 | |
|